1. Home
  2. BTU vs CGON Comparison

BTU vs CGON Comparison

Compare BTU & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BTU
  • CGON
  • Stock Information
  • Founded
  • BTU 2016
  • CGON 2010
  • Country
  • BTU United States
  • CGON United States
  • Employees
  • BTU N/A
  • CGON N/A
  • Industry
  • BTU Coal Mining
  • CGON
  • Sector
  • BTU Energy
  • CGON
  • Exchange
  • BTU Nasdaq
  • CGON NYSE
  • Market Cap
  • BTU 2.8B
  • CGON 2.4B
  • IPO Year
  • BTU N/A
  • CGON 2024
  • Fundamental
  • Price
  • BTU $20.64
  • CGON $28.67
  • Analyst Decision
  • BTU Strong Buy
  • CGON Strong Buy
  • Analyst Count
  • BTU 4
  • CGON 8
  • Target Price
  • BTU $29.00
  • CGON $63.88
  • AVG Volume (30 Days)
  • BTU 2.9M
  • CGON 932.1K
  • Earning Date
  • BTU 02-06-2025
  • CGON 02-02-2025
  • Dividend Yield
  • BTU 1.45%
  • CGON N/A
  • EPS Growth
  • BTU N/A
  • CGON N/A
  • EPS
  • BTU 3.78
  • CGON N/A
  • Revenue
  • BTU $4,348,600,000.00
  • CGON $684,000.00
  • Revenue This Year
  • BTU N/A
  • CGON $162.50
  • Revenue Next Year
  • BTU N/A
  • CGON $17.62
  • P/E Ratio
  • BTU $5.42
  • CGON N/A
  • Revenue Growth
  • BTU N/A
  • CGON 258.12
  • 52 Week Low
  • BTU $20.21
  • CGON $25.77
  • 52 Week High
  • BTU $29.94
  • CGON $50.23
  • Technical
  • Relative Strength Index (RSI)
  • BTU 25.25
  • CGON 34.14
  • Support Level
  • BTU $20.95
  • CGON $27.00
  • Resistance Level
  • BTU $21.93
  • CGON $30.00
  • Average True Range (ATR)
  • BTU 0.72
  • CGON 2.03
  • MACD
  • BTU -0.14
  • CGON -0.42
  • Stochastic Oscillator
  • BTU 3.80
  • CGON 17.16

About BTU Peabody Energy Corporation

Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. Powder River Basin segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: